CoChat

3D Bioprinting of Breast Cancer Models for Drug Resistance Study

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

Adipose-derived mesenchymal stem/stromal cells (ADMSC) are one of the major stromal cells in the breast cancer microenvironment that promote cancer progression. Previous studies on the effects of ADMSC on breast cancer metastasis and drug resistance, using two-dimensional (2D) cultures, remained inconclusive. In the present study, we compared cocultured ADMSC and human epidermal receptor 2 positive breast primary breast cancer cells (21PT) in 2D and three-dimensional (3D) cultures and then examined their response to doxorubicin (DOX). We examined 3D bioprinted constructs with breast cancer cells in the middle and ADMSC in the edge region, which were made by using dual hydrogel-based bioinks. We found that the percentage of cleaved Caspase-3 positive cells was significantly lower in the bioprinted constructs with ADMSC and 21PT than that in the cancer cell alone constructs, in response to low DOX dose. We further increased the thickness of the ADMSC layers to mimic the status of obesity and then examined the effect of ADMSC thickness on DOX resistance and lysyl oxidase (LOX) secretion. In the moderate and thick-layered ADMSC constructs, significantly more cells were stained negative for cleaved Caspase-3, indicating less apoptosis. Both ADMSC and 21PT intrinsically expressed LOX, regardless of changes in thickness or DOX administration. Notably, treatment with a LOX inhibitor significantly decreased the stiffness in the ADMSC region but did not affect the stiffness in the 21PT region. In addition, LOX inhibitor treatment enhanced DOX sensitivity of 21PT in the bioprinted constructs, as seen by a decrease in LOX secretion and downregulation of adenosine triphosphate-binding cassette transporter gene expression. Taken together, we demonstrate that 3D bioprinted these breast cancer models faithfully reproduce in vivo conditions and should provide better models for examining breast cancer biology and for screening for drug discoveries.

Overview

Integrity signals

Registry

Crossref · 10.1021/acsbiomaterials.8b01277

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 2

  1. Kirschmann D., 2002, Cancer Res., 62, 4478
  2. Band V., 1990, Cancer Res., 50, 7351

Cited by

See all 157

Metadata

Authors
Wang, Y., Shi, W., Kuss, M., Mirza, S., Qi, D., Krasnoslobodtsev, A., Zeng, J., Band, H., Band, V., & Duan, B.
Affiliations
  • Shandong University (CN)
  • University of Nebraska Medical Center (US)
  • First Hospital of China Medical University (CN)
  • University of Nebraska at Omaha (US)
  • Fred and Pamela Buffett Cancer Center (US)
Corresponding author
  • Band, Vimla
  • Duan, Bin
Venue
ACS Biomaterials Science & Engineering
Published
2018-11-15
Volume
4
Issue
12
Pages
4401-4411
ISSN
2373-9878 (ISSN-L)
OpenAlex
W2901604183
Cited by
157
References
89
Citations by year
2026: 11 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 20 · 2021: 32 · 2020: 13 · 2019: 7
FWCI
5.20
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Biomaterials Science & Engineering (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Nebraska Department of Health and Human Services
  • University of Nebraska Medical Center
  • U.S. Department of Defense (W81XWH-17-1-0616, W81XWH-14-1-0567)
  • State of Nebraska
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
3D bioprinting, breast cancer, drug resistance, doxorubicin resistance, tumor microenvironment, lysyl oxidase, obesity, apoptosis, caspase-3, ABC transporters, tumor stiffness, HER2-positive breast cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.